DeepMed Research

RxSight

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: 374

Market Cap: -

Website

Introduction: RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Clinical Trials

RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study

Not Applicable

Completed

Conditions: Cataract
Aphakia

Interventions: Device: Light Adjustable lens (LAL) and Light Delivery Device (LDD)
Device: Control IOL

First Posted Date: 2022-01-24

Last Posted Date: 2025-04-20

Lead Sponsor: RxSight, Inc.

Target Recruit Count: 500

Registration Number: NCT05202808

Locations: 🇺🇸
Slade & Baker Vision, Houston, Texas, United States
🇺🇸
Vold Vision, Fayetteville, Arkansas, United States
🇺🇸
Reeve Woods Eye Center, Chico, California, United States

and more 10 locations

Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes

Completed

Conditions: Cataract
Aphakia

First Posted Date: 2020-08-27

Last Posted Date: 2025-02-10

Lead Sponsor: RxSight, Inc.

Target Recruit Count: 79

Registration Number: NCT04529616

Locations: 🇲🇽
CODET Vision Institute, Tijuana, Mexico

A Clinical Study to Evaluate The Safety and Effectiveness of The RxSight Light Adjustable Lens (LAL) In Subjects Desiring an Extended Depth of Focus

Terminated

Conditions: Aphakia
Cataract
Presbyopia

First Posted Date: 2019-11-26

Last Posted Date: 2025-01-07

Lead Sponsor: RxSight, Inc.

Target Recruit Count: 34

Registration Number: NCT04177771

Locations: 🇺🇸
Vold Vision, Fayetteville, Arkansas, United States

A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)

Not Applicable

Completed

Conditions: Aphakia
Cataract

Interventions: Device: Light Delivery Device (LDD)

First Posted Date: 2019-07-02

Last Posted Date: 2021-06-11

Lead Sponsor: RxSight, Inc.

Target Recruit Count: 25

Registration Number: NCT04005586

Locations: 🇺🇸
Cleveland Eye Clinic, Brecksville, Ohio, United States
🇺🇸
Vance Thompson Vision Clinic, Sioux Falls, South Dakota, United States

Exploratory Study to Evaluate the Use of the RxSight Light Adjustable Lens (LAL) and the Light Delivery Device (LDD) to Improve Visual Outcomes

Completed

Conditions: Aphakia
Cataract

Interventions: Device: Light Adjustable lens (LAL) and Light Delivery Device (LDD)

First Posted Date: 2019-03-29

Last Posted Date: 2022-05-12

Lead Sponsor: RxSight, Inc.

Target Recruit Count: 66

Registration Number: NCT03895034

Locations: 🇲🇽
CODET Vision Institute, Tijuana, Mexico

Clinical Study to Evaluate the RxSight Light Adjustable Lens With the Light Delivery Device in Subjects With Preoperative Corneal Astigmatism

Not Applicable

Completed

Conditions: Cataract

Interventions: Device: RxSight RxLAL

First Posted Date: 2018-12-11

Last Posted Date: 2021-06-09

Lead Sponsor: RxSight, Inc.

Target Recruit Count: 55

Registration Number: NCT03771352

Locations: 🇩🇪
University Eye Clinic, Heidelberg, Germany
🇬🇧
Ayrshire Eye Clinic and Laser Center, Ayr, Scotland, United Kingdom

Exploratory Study to Evaluate Uncorrected Distance Vision and Quality of Vision After Light Treatments of an Implanted RxSight Light Adjustable Lens (RXLAL) With The Light Delivery Device (LDD) in Subjects With Preoperative Corneal Astigmatism

Not Applicable

Completed

Conditions: Aphakia
Cataract

Interventions: Device: Light Adjustable lens (LAL) and Light Delivery Device (LDD)

First Posted Date: 2018-11-02

Last Posted Date: 2021-08-06

Lead Sponsor: RxSight, Inc.

Target Recruit Count: 21

Registration Number: NCT03729024

Locations: 🇲🇽
CODET Vision Institute, Tijuana, Mexico

Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery

Not Applicable

Completed

Conditions: Aphakia
Cataract

Interventions: Device: Control IOL
Device: Light Adjustable lens (LAL) and Light Delivery Device (LDD)

First Posted Date: 2018-09-07

Last Posted Date: 2021-12-23

Lead Sponsor: RxSight, Inc.

Target Recruit Count: 105

Registration Number: NCT03660865

Locations: 🇺🇸
Focal Point Vision, San Antonio, Texas, United States
🇺🇸
Cleveland Eye Clinic, Brecksville, Ohio, United States
🇺🇸
The Eye Institute of Utah, Salt Lake City, Utah, United States

and more 3 locations

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy